LSV Asset Management’s GSK GSK Stock Holding History

LSV Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Hold	25,000	–	–	﹤0.01%	640
2026 Q1	$1.38M	Hold	25,000	–	–	﹤0.01%	614
2025 Q4	$1.23M	Hold	25,000	–	–	﹤0.01%	621
2025 Q3	$1.08M	Hold	25,000	–	–	﹤0.01%	634
2025 Q2	$960K	Buy	25,000 +2,240	+10%	+$85.6K	﹤0.01%	614
2025 Q1	$882K	Hold	22,760	–	–	﹤0.01%	633
2024 Q4	$770K	Sell	22,760 -3,300	-13%	-$119K	﹤0.01%	632
2024 Q3	$1.06M	Buy	26,060 +2,020	+8%	+$82.6K	﹤0.01%	636
2024 Q2	$926K	Sell	24,040 -1,380	-5%	-$58K	﹤0.01%	683
2024 Q1	$1.09M	Hold	25,420	–	–	﹤0.01%	677
2023 Q4	$942K	Hold	25,420	–	–	﹤0.01%	693
2023 Q3	$921K	Sell	25,420 -2,820	-10%	-$100K	﹤0.01%	689
2023 Q2	$1.01M	Hold	28,240	–	–	﹤0.01%	692
2023 Q1	$1M	Hold	28,240	–	–	﹤0.01%	665
2022 Q4	$992K	Hold	28,240	–	–	﹤0.01%	654
2022 Q3	$831K	Hold	28,240	–	–	﹤0.01%	663
2022 Q2	$1.54M	Sell	28,240 -52,240	-65%	-$2.88M	﹤0.01%	630
2022 Q1	$4.38M	Sell	80,480 -51,600	-39%	-$2.8M	0.01%	541
2021 Q4	$7.28M	Sell	132,080 -9,600	-7%	-$499K	0.01%	494
2021 Q3	$6.77M	Hold	141,680	–	–	0.01%	500
2021 Q2	$7.05M	Hold	141,680	–	–	0.01%	500
2021 Q1	$6.32M	Sell	141,680 -360,000	-72%	-$16.3M	0.01%	529
2020 Q4	$23.1M	Sell	501,680 -98,560	-16%	-$4.53M	0.04%	347
2020 Q3	$28.2M	Hold	600,240	–	–	0.06%	287
2020 Q2	$30.6M	Buy	600,240 +149,040	+33%	+$7.65M	0.06%	284
2020 Q1	$21.4M	Buy	451,200 +7,120	+2%	+$380K	0.05%	292
2019 Q4	$26.1M	Buy	444,080 +640	+0.1%	+$35.6K	0.04%	343
2019 Q3	$23.7M	Buy	443,440 +1,200	+0.3%	+$61.7K	0.04%	352
2019 Q2	$22.1M	Buy	442,240 +108,000	+32%	+$5.42M	0.04%	362
2019 Q1	$17.5M	Sell	334,240 -5,960	-2%	-$298K	0.03%	394
2018 Q4	$16.2M	Sell	340,200 -44,320	-12%	-$2.18M	0.03%	394
2018 Q3	$19.3M	Buy	384,520 +12,280	+3%	+$624K	0.03%	393
2018 Q2	$18.8M	Sell	372,240 -3,360	-0.9%	-$169K	0.03%	395
2018 Q1	$18.3M	Sell	375,600 -1,120	-0.3%	-$52.2K	0.03%	396
2017 Q4	$16.7M	Buy	376,720 +87,600	+30%	+$4.05M	0.03%	412
2017 Q3	$14.7M	Hold	289,120	–	–	0.02%	425
2017 Q2	$15.6M	Sell	289,120 -10,320	-3%	-$550K	0.03%	398
2017 Q1	$15.8M	Buy	299,440 +47,680	+19%	+$2.42M	0.03%	390
2016 Q4	$12.1M	Buy	251,760 +43,120	+21%	+$2.13M	0.02%	431
2016 Q3	$11.2M	Buy	208,640 +5,120	+3%	+$281K	0.02%	417
2016 Q2	$11M	Buy	203,520 +19,840	+11%	+$1.05M	0.02%	404
2016 Q1	$9.31M	Sell	183,680 -5,520	-3%	-$275K	0.02%	419
2015 Q4	$9.54M	Hold	189,200	–	–	0.02%	403
2015 Q3	$9.09M	Buy	189,200 +138,560	+274%	+$7.21M	0.02%	402
2015 Q2	$2.64M	Hold	50,640	–	–	0.01%	587
2015 Q1	$2.92M	Hold	50,640	–	–	0.01%	558
2014 Q4	$2.71M	Buy	50,640 +3,120	+7%	+$175K	0.01%	564
2014 Q3	$2.73M	Buy	47,520 +17,520	+58%	+$1.07M	0.01%	553
2014 Q2	$2M	Buy	+30,000	New	+$2.03M	﹤0.01%	591

Other funds holding GSK

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

LSV Asset Management's GSK Position: Q2 2026 in Review

LSV Asset Management held its GSK (GSK) position steady in Q2 2026 at 25,000 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #640.

LSV Asset Management first reported a position in GSK in Q2 2014 and has held it in 49 quarters since. The position peaked at $30.6M in Q2 2020. 683 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

LSV Asset Management held 25,000 shares of GSK worth $1.31M as of Q2 2026.
LSV Asset Management left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #640 holding.
LSV Asset Management first reported a position in GSK in Q2 2014 and has held it in 49 quarters since.
LSV Asset Management's GSK position peaked at $30.6M in Q2 2020.
683 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.